Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4422 is a small, non-coding RNA molecule found in humans, classified as a microRNA (miRNA). miR-4422-5p acts as a post-transcriptional regulator, suppressing the expression of BACE1 and GSAP—enzymes central to amyloid precursor protein cleavage—in vitro, thus implicating it as a putative biomarker and therapeutic candidate for Alzheimer’s disease. Like other miRNAs, it exerts its function through sequence-specific binding to target messenger RNAs, resulting in translational repression or mRNA degradation. No direct drug interactions have been documented; miR-4422 is not associated with established pharmacological agents, but synthetic mimics/inhibitors are tools for mechanistic studies. Broader roles in other diseases or biological processes are currently undocumented in publicly available biomedical literature.
Suppression of BACE1 and GSAP by direct targeting of their mRNA 3′ UTR, leading to decreased protein expression\nGeneral microRNA mechanism: sequence-specific binding to target mRNA resulting in translational inhibition or degradation
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4422 (miR-4422).